titolo pharma americano con 1 prodotto in rampa di lancio decisamente interessante in quanto al terzo step di approvazione, potrebbe essere una buy opp
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.